Bulk wakix

Ended Awarded

Contract number
36C26025F0303
Awardee
Awarding agency
Obligated
$39,243

Award facts

Contract value 100% obligated
$39,243.48 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Pittsburgh, PA 15205, USA

Award details come from SAM.gov/FPDS.

About this award

This is a federal contract award to Harmony Biosciences LLC, a pharmaceutical company based in Pennsylvania, for the procurement of WAKIX (pitolisant), a medication used to treat excessive daytime sleepiness and cataplexy in adult narcolepsy patients. The contract was awarded by the Department of Veterans Affairs (VA) under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is a delivery order with a ceiling value of $39,243.48 and a period of performance ending on September 30, 2025. No set-aside designation was used for this award. Harmony Biosciences LLC holds two larger federal contract vehicles with the VA for WAKIX procurement, including a $5 million Blanket Purchase Agreement and a $259,000 multiple award indefinite-delivery indefinite-quantity (IDIQ) contract, both under the same Federal Supply Schedule. These contract vehicles have enabled the VA to streamline the acquisition of WAKIX and related pharmaceutical products across its facilities.

Quick answers

Who was awarded contract 36C26025F0303?

36C26025F0303 was awarded to Harmony Biosciences LLC by Veterans Integrated Service Network 20 (Veterans Health Administration) on June 23, 2025.

How much is contract 36C26025F0303 worth?

The government has obligated $39,243 on 36C26025F0303.

Is contract 36C26025F0303 an order under another contract?

Yes. 36C26025F0303 is a delivery order under 36F79720D0148, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C26025F0303 competed?

The extent of competition for 36C26025F0303 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award